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ABSTRAK 
 
BAHASA MALAYSIA 
TAJUK 
Perbandingan profil klinikal dan biokimia sindrom metabolik antara kanak-kanak obes di 
bawah 10 tahun dengan 10 tahun ke atas yang mengikuti rawatan susulan di Klinik Kanak-
Kanak HUSM dari 2006 ke 2015 
 
PENGENALAN 
Masalah obesiti di kalangan kanak-kanak semakin berleluasa. Bilangan kanak-kanak obes 
yang semakin meningkat menyebabkan pertambahan kes sindrom metabolik, sekumpulan 
gangguan biokimia yang jika tidak dikawal akan meningkatkan risiko berlakunya penyakit 
jantung dan diabetis di peringkat dewasa kelak. Kajian sebelumnya melaporkan kadar 
sindrom metabolik yang berbeza disebabkan tiada definasi ‘paediatric metabolic syndrome’ 
yang diterima secara umum.  
 
OBJEKTIF 
Untuk menentukan sekiranya terdapat perbezaan ketara sifat klinikal dan biokimia untuk 
sindrom metabolik antara kanak-kanak obes di bawah 10 tahun dengan kanak-kanak obes 10 
tahun ke atas yang telah manjalani rawatan susulan di Klinik Pediatrik HUSM dari tahun 
2006 ke 2015. 
 
KAEDAH 
Rekod perubatan 84 kanak-kanak obes di bawah 18 tahun yang telah manjalani rawatan 
susulan di Klinik Pediatrik HUSM dari tahun 2006 ke 2015 dikenalpasti. Maklumat  
demografik (umur, jantina, kumpulan etnik), klinikal (berat badan, BMI, lilitan pinggang, 
tekanan darah) dan keputusan makmal (serum triglyceride, total cholesterol, HDL-
cholesterol, LDL- cholesterol, fasting blood sugar) mereka direkod, dianalisa dan 
dibandingkan.  
 
 
x 
KEPUTUSAN 
Bilangan kanak-kanak dibawah 10 tahun yang obes (41 pesakit) hampir sepadan dengan 
bilangan kanak-kanak obes yang berumur 10 tahun ke atas (43 pesakit). Kebanyakan pesakit 
di dalam kedua-dua kumpulan umur merupakan lelaki, iaitu 68.2% daripada kanak-kanak 
obes di bawah 10 tahun berbanding dengan 62.8% daripada kanak-kanak obes 10 tahun ke 
atas. Umur purata pesakit adalah 9.69 tahun. Bilangan pesakit yang  menghidapi sindrom 
metabolik mengikut kriteria diagnosa IDF adalah 11 pesakit di bawah 10 tahun dan 12 
pesakit dengan umur melebihi 10 tahun. Seperti yang dijangka, BMI, lilitan pinggang, 
tekanan darah sistolik, dan paras triglyceride adalah lebih tinggi dalam kanak-kanak >10 
tahun. Tiada perbezaan ketara dalam berat lahir, tekanan darah diastolik, paras kolesterol, 
HDL, LDL atau fasting plasma glucose antara kedua-dua kumpulan yang dikaji.      
 
 
KESIMPULAN 
Keputusan kajian ini menunjukkan bahawa 31% kanak-kanak obes yang menjalani rawatan 
susulan di Klinik Pediatrik HUSM turut menghidapi sindrom metabolik. Angka ini adalah 
sebanding dengan keputusan kajian yang dijalankan di negara maju. Pengesanan komponen 
sindrom metabolik di kalangan kanak-kanak berumur bawah 10 tahun merupakan 
perkembangan yang membimbangkan. Justeru itu, langkah-langkah untuk mencegah masalah 
obesiti di kalangan kanak-kanak perlu dipertingkatkan.     
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ABSTRACT 
 
ENGLISH 
TITLE 
Comparison of the clinical and biochemical profile of metabolic syndrome between obese 
children below and above 10 years attending paediatric clinic HUSM from 2006 to 2015 
 
INTRODUCTION 
The burgeoning childhood obesity epidemic predisposes increasing numbers of children to 
the biochemical derangements that constitute metabolic syndrome, a cluster of metabolic risk 
factors that if unchecked can progress towards the development of cardiovascular disease and 
diabetes with their attendant morbidity and mortality in adulthood. Previous studies in 
children had reported varying rates of prevalence due to a lack of a universally accepted 
definition for paediatric metabolic syndrome.  
 
OBJECTIVE 
To determine if there is a significantly different clinical and biochemical profile of metabolic 
syndrome between obese children below and above 10 years attending Paediatric Clinic 
HUSM from 2006-2015 
 
METHODS 
The medical records of 84 obese children under 18 years of age who were followed up at 
Paediatric clinic HUSM from 2006 to 2015 were identified and had their demographic (age, 
gender, ethnicity), anthropometric, (weight and height), clinical (BMI, systolic and diastolic 
blood pressure) and biochemical (serum triglyceride, total cholesterol, HDL-cholesterol, 
LDL- cholesterol, fasting blood sugar) parameters recorded, analysed and compared.  
 
RESULTS 
The majority of subjects in both age groups were boys, 68.2% of those less than 10 years and 
62.8% in those above 10 years. Mean age of subjects was 9.69 years. An almost equal 
xii 
number of children had been brought to medical attention for obesity (41 vs 43) and fulfil the 
IDF criteria for metabolic syndrome (11 vs 12) in both groups. As expected, the mean body 
mass index, waist circumference, systolic blood pressure, and serum triglyceride levels are 
significantly higher in children >10 years of age. There were no significant differences in 
birth weight, diastolic blood pressure, total cholesterol, HDL cholesterol, LDL cholesterol or 
fasting plasma glucose levels between the 2 groups. 
 
CONCLUSION 
The data obtained during this study demonstrates a high prevalence rate (31%) of metabolic 
syndrome among obese children attending paediatric clinic in HUSM, which is comparable to 
findings from other studies in developed countries. In view of the alarming presence of 
components of metabolic syndrome even in children less than 10 years of age, efforts aimed 
at the prevention of childhood obesity in the community should be stepped up.   
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CHAPTER 1: INTRODUCTION 
 
 
 
 
 
 
1 
CHAPTER 1: INTRODUCTION 
 
1.1 Background 
 
According to the World Health Organization’s (WHO) Interim Report of the 
Commission on Ending Childhood Obesity 2015, an estimated 42 million children 
worldwide in 2013 are overweight or obese, with 18 million of these children in Asia(1). 
This is a problem of rapidly increasing magnitude even in developing countries especially 
in urban areas.  
 
 In Malaysia, the Ministry of Health’s National Health and Morbidity Survey (NHMS) 
2015 Factsheet(2) shows an alarming surge in the proportion of children less than 18 
years who are obese from 3.9% (0.3 million) in 2011 to 11.9% (1 million) in 2015. 
Without prompt intervention, childhood obesity will track into adulthood (3-5), leading to 
the development of myriad complications which increase morbidity and mortality, reduce 
life expectancy and quality of life.  
 
 Metabolic syndrome is a constellation of metabolic derangements consisting of 
abdominal obesity, dyslipidemia, hypertension and raised plasma glucose(6, 7) that 
significantly increases the risk of developing Type 2 diabetes and premature 
arteriosclerotic cardiovascular disease. 
 
1.2 Paediatric Metabolic syndrome 
 
Paediatric metabolic syndrome has been noted to have an increased prevalence in 
obese adolescents with rates as high as 28.7% (3) according to data from the US National 
Health and Nutrition Examination Survey 1988-1994. Unfortunately, no single unified 
definition for paediatric metabolic syndrome has been adopted until the formulation of the 
International Diabetes Federation Consensus Definition in 2005. It is vital that this 
condition is diagnosed early to enable the prompt institution of early childhood lifestyle 
interventions to prevent progression and development of complications.  
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1.3 Literature Review 
 
A search of relevant literature was conducted using Pubmed and Google Scholar 
which revealed a number of articles of interest including some published locally.  
 
 In 2003, Cook, Weitzman et al. 2003, published data from the US National Health and 
Nutrition Examination Survey (NHANES) conducted between 1988-94 involving 2430 
patients aged 12-19 years which determined that while risk factors for metabolic syndrome 
tended to cluster in obese adolescents, 31.4% of participants with BMI <85th percentile had 
one risk factor for metabolic syndrome. In overweight adolescents (BMI 85-95th percentile), 
54.4% and 23.2% respectively had 1 and 2 risk factors for metabolic syndrome in comparison 
with obese adolescents (BMI>95th percentile), which were 88.5% and 56% respectively. 
Plasma glucose levels in overweight participants were also higher than those in obese 
participants (4.5%, 95% CI: 0-9.5 vs 2.6%, 95% CI: 0-6.3). Among the conclusions the 
authors arrived at was that waist circumference was a more sensitive indicator of central fat 
distribution, the essential component of metabolic syndrome, compared to BMI. 
Unfortunately, paediatric metabolic syndrome had not yet been properly defined at the time 
this study was conducted in 2003, causing the researchers to base their diagnosis of metabolic 
syndrome on the National Cholesterol Education Program Adult Treatment Panel III (NCEP 
ATP III) criteria, which were extrapolated from the adult population. The cross sectional 
nature of this study also limited the conclusions that could be drawn from it with regards to 
the causation and progression of paediatric metabolic syndrome.  
 
 Weiss et al(8), applied similar criteria to a wider age group of 439 children aged 4-20 
years in 2004. The prevalence of metabolic syndrome as determined from their study was 
38.7% in moderately obese (BMI>95th percentile) vs 49.7% in severely obese (BMI>98th 
percentile) children, respectively. Comparison of the various elements of metabolic syndrome 
such as high plasma glucose, triglycerides, systolic blood pressure and low HDL was also 
carried out between overweight and obese groups and were found to increase (or decrease in 
the case of HDL) with increasing BMI. It can therefore be surmised that the prevalence of 
metabolic syndrome increased with increasing obesity, and was higher in obese compared to 
3 
overweight subjects. Subjects followed up by the authors in 2 years continued to demonstrate 
persistence and progression of the phenotype for metabolic syndrome, with development of 
type 2 diabetes in 8 patients. Unfortunately, most of the analysis carried out by the authors 
focussed on moderately and severely obese subjects. Conclusions comparing overweight and 
obese children had to be independently inferred.  
 
 A review article by the same author (9) stressed on the importance of a thorough 
history and clinical examination to locate clues for the identification of children at risk of 
developing metabolic complications of childhood obesity stemming from insulin resistance. 
The importance of assessment of the degree of visceral adiposity in view of its association 
with increased metabolic risk was emphasized. The author also reminded clinicians to 
maintain a high index of suspicion for clinically silent conditions such as impaired glucose 
tolerance and non-alcoholic fatty liver disease, which may be present in this group of high 
risk children.    
 
 Several local researchers have also explored the prevalence of metabolic syndrome in 
the paediatric population. Quah et al (10) conducted a study on 78 schoolchildren aged 8-10 
years old from Kuala Lumpur in 2010. They found that 17.9% of participants can be 
classified as obese, with a prevalence of metabolic syndrome by IDF 2005 criteria of 2.9% of 
obese participants. The relatively low prevalence of metabolic syndrome even in obese 
subjects in comparison with foreign studies was attributed to the high cut-off values used by 
the IDF criteria. Comparison of obese with normal weight children was also carried out, and 
it was found that 9.1% of normal weight children had 1 risk factor for metabolic syndrome, 
which was unfortunately not specified. Additionally, the lack of local waist circumference 
percentile charts at the time this study was carried out, considering that abdominal adiposity 
is an essential component of the IDF 2005 criteria for metabolic syndrome may have 
hampered this study. Another aspect that we hope to improve on in our study is the relatively 
narrow age range (8-10 years) of this study’s participants. 
 
 Wee (11) and colleagues examined 402 participants aged 9-12 years in Kuala Lumpur 
for the risk factors of metabolic syndrome and determined the prevalence of 
overweight/obesity at 5.3%. Subjects with metabolic syndrome by IDF 2005 criteria 
4 
comprised 5.3% of obese participants which is still lower compared to previously conducted 
US studies. 88% of obese participants had at least 1 risk factor for metabolic syndrome, while 
14% of normal weight had a similar number of risk factors. Comparison between overweight 
and obese subjects was not carried out in this study. The researchers also calculated the 
prevalence of metabolic syndrome solely in overweight/obese participants. This study was 
also unable to refer to age/gender specific local waist circumference standards. The authors 
attributed the lack of association between age, gender and ethnicity with metabolic syndrome 
to the study’s small sample size.  
 
 The study conducted by Fadzlina et al (12) in 2014 on 1014 schoolchildren revealed 
that 25.4% or 258 of the subjects were overweight/obese. Of these, 16% were in the 
overweight group while 9.4% were in the obese group. Prevalence of metabolic syndrome by 
IDF 2005 criteria was 2.6% of the general population and 10% of overweight/obese 
participants. Comparison of overweight/obese with normal weight subjects showed that the 
risk factors for metabolic syndrome were predominantly clustered in the overweight/obese 
group. The limitation of this study is that it was confined only to children aged 13 years old 
and comparison of risk factors between overweight and obese children was not included.  
 
 Utilizing data from the Kiel Obesity Prevention Study, Danielzik et al (13) had 
concluded that a higher birth weight was a major determinant in the development of obesity 
in children, in addition to parental overweight and socioeconomic status. Boney et al (14) had 
almost similar findings, concluding that maternal gestational diabetes (OR 10.4, 95% CI: 1.5-
74.4) and a large for gestational age birth weight (OR 4.3, 95% CI: 1.5-11.9) were associated 
with the development of insulin resistance, and subsequently metabolic syndrome in 
childhood. On the other hand, Rossi et al (15) found no significant difference in the birth 
weights of obese children in comparison with normal children or any association between 
those born small for gestational age and the development of future obesity. 
 
 Madeira and colleagues (16) studied the impact of obesity on the components of 
metabolic syndrome in prepubertal children aged 2-11 years and reported a predictable 
decrease in HDL cholesterol and other anti-atherogenic markers in overweight and obese 
children in comparison with normal weight children. Hyperinsulinemia and indices of insulin 
5 
resistance were also found to be significantly higher in overweight and obese children. 
Another study conducted by Ferreira et al (17) demonstrated a positive association between 
insulin resistance and risk factors for the development of cardiovascular disease. The authors 
reported that metabolic syndrome was only diagnosed in obese children, and that the 
frequency of metabolic syndrome and number of its components increased with worsening 
degree of insulin resistance. In contrast with other studies, Ferreira also noted a more 
significant Spearman correlation coefficient between BMI and development of metabolic 
syndrome (r=0.77) in comparison with waist circumference (r=0.7).  
 
1.4 Study Rationale 
 
This study aims to compare the clinical and biochemical profile of metabolic syndrome in 
obese children less than and more than 10 years of age attending paediatric clinic HUSM and 
determine if there are any significant differences in the clinical and biochemical parameters 
among these two groups. Body mass index is a less sensitive indicator of abdominal adiposity 
in comparison with waist circumference as it does not account for body fat distribution. 
Children with lower BMI but with greater waist circumference is at higher risk of having 
metabolic syndrome compared to a child with higher BMI but lower waist circumference.  
 
The cut-off point of age of 10 years was chosen as it is the average age of onset of 
puberty (18, 19) in both sexes in lieu of formal pubertal assessment in the form of Tanner 
staging. Puberty is associated with increased insulin resistance, which is the primary 
pathophysiologic mechanism for the development of metabolic syndrome. Therefore, it is 
hoped that this study will be able to demonstrate if there is any significant difference in the 
outcomes which predict predisposition to metabolic syndrome between these two groups of 
obese children.  
 
In addition, it is also hoped that this study will contribute to the available pool of local 
data on obesity in the paediatric population. This will help determine the magnitude of this 
problem locally and guide the optimal utilization of available local healthcare resources. By 
recording the demographic characteristics and clinical and biochemical parameters in these 
6 
children, it will lead to a standardized clinical approach for the assessment of a child 
presenting with obesity.  
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CHAPTER 2: OBJECTIVES 
 
2.1 General Objective 
To determine if there is a significantly different clinical and biochemical profile of metabolic 
syndrome between obese children below and above 10 years attending Paediatric Clinic 
HUSM from 2006-2015 
 
2.2 Specific Objectives: 
1. To compare the clinical and biochemical profiles of metabolic syndrome in 
obese children below and above 10 years attending Pediatric Clinic HUSM 
between 2006-2015 
2. To determine if different age groups in obese children lead to significantly 
different outcomes with regards to the clinical and biochemical risks for 
development of metabolic syndrome 
 
2.3 Research Hypothesis 
There is a significantly differences in the clinical and biochemical profile of metabolic 
syndrome in obese children below and above 10 years attending Pediatric Clinic HUSM 
between 2006-2015 
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CHAPTER 3: METHODOLOGY 
 
3.1 Study Design 
Retrospective study 
 
3.2 Study Setting 
Paediatric Clinic Hospital Universiti Sains Malaysia 
 
3.3 Study population 
Reference population – Obese children <18 years old in Kelantan 
Source population – Obese children <18 years old followed up at paediatric clinic HUSM  
Target population- Overweight and obese children <18 years old followed up at paediatric 
clinic HUSM from 2006-2015 
Sampling frame – List of overweight and obese patients followed up at paediatric clinic 
HUSM from 2006-2025 obtained with the assistance of HUSM record office 
 
3.4 Sample Size Calculation 
Sample size estimation for objective 2 
 
Sample size is calculated using Power and Sample size Calculations v3.0 © Dupont & 
Plummer using 2 proportion (Pocock) formula for each of the studied variables with 
α= 0.05 (95% confidence interval) 
Power of study=0.8 
m=1 
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1. Waist circumference >90th percentile 
Cook et al  
 Overweight,n= 366 
WC>90th percentile 11.5% 
 
P1 = 0.9 
P0 = 0.745 
Calculated sample size, n= 94 
 
2. Systolic blood pressure >130mmHg 
Fadzlina et al  
 Non-obese, n=756 
SBP>130mmHg 1.19% 
 
P1 = 0.3 
P0 = 0.1395 
Calculated sample size, n= 103 
 
3. Diastolic blood pressure > 90mmHg 
Fadzlina et al  
 Non-obese, n= 756 
DBP> 90mmHg 3.17% 
 
P1 = 0.25 
P0 = 0.1007 
Calculated sample size, n= 101 
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4. Fasting plasma glucose > 5.6mmol/L 
Wee et al   
 Normal weight, n=193 
FPG>5.6mmol/L 5.2% 
 
P1 = 0.18 
P0 = 0.058 
Calculated sample size, n= 109 
 
5. HDL-Cholesterol < 1.03mmol/L 
Cook et al   
 Overweight,n= 366 
HDL-C<1.03mmol/L  32.3% 
 
P1 = 0.7 
P0 = 0.5 
Calculated sample size, n= 93 
 
6. Triglycerides >1.24mmol/L 
Cook et al  
 Overweight,n= 366 
TG>1.24mmol/L 33.5% 
 
 P1 = 0.72 
P0 = 0.518 
Calculated sample size, n= 90 
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7. Age 12-19 years  
 
Wang & Beydoun et al  
 Overweight 
Age 12-19 years 34.3% 
 
P1 = 0.343 
P0 = 0.174 
Calculated sample size, n= 104 
 
8. Male sex 
Wang & Beydoun et al  
 Overweight 
Males 34.8% 
 
P1 = 0.348 
P0 = 0.182 
Calculated sample size, n= 110 
 
9. Small for gestational age (SGA) 
Danielzik et al  
 Overweight, n=161 
SGA 3.3% 
 
P1 = 0.2 
P0 = 0.043 
Calculated sample size, n= 67 
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10. Large for gestational age (LGA) 
Danielzik et al  
 Overweight, n=161 
LGA 19.6% 
 
P1 = 0.6 
P0 = 0.37 
Calculated sample size, n= 73 
 
11. Physical activity < 1 hour/day 
Danielzik et al  
 Overweight, n=161 
Activity<1hour/day 41.4% 
 
P1 = 0.55 
P0 = 0.33 
Calculated sample size, n= 81 
 
In conclusion, the required sample size for objective 2 is: 110 subjects  
 
3.5 Sampling Methods 
No sampling method applied 
 
3.6 Study Subjects 
 
3.6.1 Inclusion criteria 
All children aged <18 years old on Paediatric clinic follow up for obesity (BMI >95th centile 
for age & sex based on CDC growth charts) at HUSM between 2006-2015 
15 
 
3.6.2 Exclusion criteria 
1. Underlying syndrome/disease or use of medications affecting body fat   
composition/distribution e.g. Cushing’s, hypothyroidism, Prader willi 
2. Use of medication which may alter body glucose/lipid metabolism and/or 
antihypertensives 
 
3.6.3 Operational definitions 
1. Overweight: BMI >85th percentile and <95th percentile for age and sex according 
to CDC growth chart 
2. Obesity: BMI at or >95th percentile for age and sex according to CDC growth 
chart 
3. Hypertension: Systolic blood pressure (SBP) and/or diastolic blood pressure 
(DBP) that is ≥95th percentile for gender, age, and height  
4. Diabetes: fasting plasma glucose level of >6.9 mmol/L or random plasma glucose 
level of >11.1 mmol/L 
5. Impaired glucose tolerance: plasma glucose level 2 hours after a 1.75g/kg 
(maximum 75g) oral glucose challenge of 7.77-11.1 mmol/L 
6. Impaired fasting glucose: fasting plasma glucose level of 5.6-6.9 mmol/L 
7. Metabolic syndrome: Abdominal Obesity: Waist circumference > 90th centile  
with 2 OR more of the following: 
 Serum triglyceride > 1.7mmol/L 
 HDL < 1.03mmol/L 
 SBP > 130mmHg or DBP> 85mmHg 
 FBS > 5.6mmol/L 
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Age Group 
(years) 
Abdominal 
Obesity (waist 
circumference) 
Triglycerides HDL-
Cholesterol 
Blood 
pressure 
Glucose 
6 to <10 
years 
>90th centile Excluded due to insufficient data but strong message for 
weight reduction in patients with WC >90th centile  
10 to <16 
years 
>90th centile >1.7mmol/L 
 
 Systolic 
>130/ 
Diatolic 
>85mmHg 
>5.6mmol/L 
 
>16 years >94cm for 
men,  
>80cm for 
women  
>1.7mmol/L 
 
<1.03 
mmol/L in 
males, 
<1.29 
mmol/L in 
females 
Systolic 
>130/ 
Diatolic 
>85mmHg 
 
>5.6mmol/L 
 
 
Variable Definition 
Quantitative Variables Categorical Variables 
Waist circumference>90th percentile for age 
& sex 
Age 
High systolic blood pressure>130mmHg or 
diastolic blood pressure >85mmHg 
Sex 
Triglycerides>1.7mmol/L Small for gestational age (SGA) 
HDL-Cholesterol<1.03mmol/L Large for gestational age (LGA) 
Fasting blood sugar >5.6mmol/L Physical activity 
 
3.7 Research Tool 
Refer appendix 1 for study Proforma/Data collection sheet 
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3.8 Study Procedure 
Patients under 18 years old who are undergoing or who have previously been 
followed up at Paediatric clinic HUSM for overweight or obesity over a 10-year period from 
2006 to 2015 are identified with the assistance of the HUSM record office. The patient 
folders are traced and the patients’ demographic, anthropometric, clinical and biochemical 
parameters are reviewed. Subjects who do not fulfil the inclusion criteria or with incomplete 
data are excluded.  The clinical and biochemical profile of eligible subjects are then 
anonymously recorded in a printed research form.  
18 
 
 
 
Fig 3.1: Flow Chart of Study 
Obese subjects who attended 
paediatric clinic HUSM from 2006-
2015 (n=101) 
Patients’ 
records 
traced 
Does not 
fulfill 
inclusion 
criteria 
Obese subjects 
< 10 years of 
age 
Obese subjects 
>10 years of age  
Record clinical and 
biochemical parameters of 
metabolic syndrome 
Comparison of clinical and 
biochemical parameters 
Eligible for 
study, n=84 
19 
3.9 Statistical Analysis 
Data will be entered and analysed using SPSS (IBM) version 22. Descriptive statistics 
will be used to summarise the socio-demographic characteristics of subjects. Numerical data 
will be presented as mean (SD) or median (IQR) based on their normality distribution. 
Categorical data will be presented as frequency (percentage).  
To test association between two categorical variables, statistical analysis will be 
carried out with either chi square test, while independent T test or Mann –Whitney test is 
used to compare means.  Association between two categorical variables with small sample 
size (<50 subjects) will be tested with Fischer Exact test.  
If the data shows irregular or non-normal distribution, a non-parametric test (Mann 
Whitney test) will be applied.  
 
3.10 Ethical Approval   
This study was approved by the Human Research Ethics Committee (HREC) USM (JEPeM 
code: USM/JEPeM/16040165) 
Refer appendix 2 
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CHAPTER 4: RESULTS 
4.1 Demographic Data 
 A total of 101 subjects were identified with the assistance of the medical records 
department to have been followed up at Paediatric clinic HUSM for obesity from 2006 to 
2015. However, only 84 of the patient records retrieved were eligible for the study, hence the 
final sample size of 84 subjects. The available patients were divided into 2 groups, Group 1 
consisting of obese children below 10 years of age, and Group 2 which comprising those 10 
years of age and above. The demographic characteristics of both groups are tabulated below 
(Table 4.1) and illustrated in Figure 4.1-4.11. (See Appendix 3-8). 
 Of the 84 available subjects, the majority in both age groups were boys, 68.2% in 
group 1 and 62.8% in group 2 respectively. Mean age of subjects was 9.69 years. Almost 
similar numbers of subjects in both age groups (18 vs 19) had a first degree relative or parent 
with obesity. It is also of note that an almost equal number of children below 10 years, in 
comparison with those more than 10 years, have already been brought to medical attention 
for obesity. Of equal concern is the almost equal number of subjects in both groups (11 vs 12) 
who fulfil the IDF criteria for metabolic syndrome. As would be expected, the mean body 
mass index, waist circumference, systolic blood pressure, and serum triglyceride levels are 
significantly higher in children >10 years of age. There were no significant differences in 
birth weight, diastolic blood pressure, total cholesterol, HDL cholesterol, LDL cholesterol or 
fasting plasma glucose levels. While subjects were distributed normally by age, other clinical 
and biochemical parameters studied did not show normal distribution, either as a whole or 
when divided into their respective groups. These parameters were therefore tested by the 
Mann Whitney U test and the findings and are tabulated below (Table 4.2). 
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Table 4.1 DEMOGRAPHIC, CLINICAL AND BIOCHEMICAL 
CHARACTERISTICS BY AGE GROUP  
Variables Below 10 years 
of age                    
(Group 1)                
n= 41 (48.8%)                        
Mean (SD) 
10 years and 
above of age           
(Group2)                 
n= 43 (51.2%)                           
Mean (SD) 
Overall 
 
n= 84                   
Mean (SD) 
Independent 
T-test            
p value   
(95% CI) 
Gender                     
Male                 
Female 
                                                                 
28 (68.2%)                                      
13 (31.7%) 
                
27 (62.8%)                            
16 (37.2%) 
                                   
55 (65.5%)                 
29 (34.5%) 
Age (years) 6.89 (2.28) 12.37 (1.51) 9.69 (3.36)  
With Metabolic 
Syndrome 
11 (26.8%) 12 (27.9%) 23 (27.4%)  
Family History of 
Obesity 
18 (43.9%) 19 (44.1%) 49 (58.3%)  
Birth weight (kg) 3.05 (0.72) 3.17 (0.8) 3.11 (0.75) 0.519 (-0.49 
to 0.25) 
BMI (kg/m2) 30.3 (6.7) 34.48 (6.74) 32.44 (7.0) <0.01 (-7.09 
to -1.26) 
Waist 
circumference 
(cm) 
90.36 (13.16) 104.8 (19.24) 98.12 (18.08) <0.01 (-23.6 
to -5.29 
Systolic BP 
(mmHg) 
107.08 (19.79) 119.93 (16.53) 113.66 (19.2) <0.01 (-20.8 
to -4.85) 
Diastolic BP 
(mmHg) 
75 (12.44) 76.84 (10.78) 75.94 (11.59) 0.477 (-6.94 
to 3.27) 
Triglyceride 
(mmol/L) 
1.32 (0.61) 1.66 (0.82) 1.49 (0.74) 0.037 (-0.65 
to -0.02) 
HDL-C (mmol/L) 1.16 (0.46) 1.09 (0.26) 1.12 (0.37) 0.475 (-0.12 
to 0.24) 
Total Cholesterol 
(mmol/L) 
4.61 (1.03) 5.21 (1.9) 4.91 (1.55) 0.082 (-1.26 
to 0.08) 
LDL-C (mmol/L) 2.88 (0.89) 3.39 (1.88) 3.14 (1.5) 0.163 (-1.23 
to 0.21) 
Fasting plasma 
glucose (mmol/L) 
4.63 (0.69) 5.25 (2.39) 4.95 (1.8) 0.118 (-1.39 
to 0.16) 
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Table 4.2: MEDIAN CLINICAL AND BIOCHEMICAL PARAMETERS BY AGE 
GROUP 
Parameters Below 10 years 
of age                    
(Group 1)                
n= 41 (48.8%)                        
Median (IQR) 
10 years and 
above of age           
(Group2)                 
n= 43 (51.2%)                           
Median (IQR) 
Z-statistic Mann 
Whitney       
p-value 
Birth weight (kg) 3.05 (0.875) 3.0 (0.8) -0.031 0.975 
BMI (kg/m2) 28.7 (8.2) 33.1 (9.1) -3.168 0.002 
Waist 
circumference 
(cm) 
90 (18.5) 99 (21.1) -3.029 0.002 
Systolic BP 
(mmHg) 
110.5 (20.25) 122 (21) -3.078 0.002 
Diastolic BP 
(mmHg) 
75 (18.75) 77.5 (16.25) -0.6 0.549 
Triglyceride 
(mmol/L) 
1.16 (0.72) 1.52 (0.88) -2.205 0.027 
HDL-C (mmol/L) 1.06 (0.34) 1.03 (0.32) -0.234 0.815 
Total Cholesterol 
(mmol/L) 
4.38 (1.03) 4.91 (1.67) -1.971 0.049 
LDL-C (mmol/L) 2.83 (0.95) 2.98 (1.4) -1.129 0.259 
Fasting plasma 
glucose (mmol/L) 
4.65 (1) 4.7 (0.6) -0.498 0.619 
 
 Chi square test was used to determine if there were any significant differences 
between the two studied age categories with regards to the various clinical (Table 4.3) and 
biochemical (Table 4.4) parameters recorded in this study, which were converted to 
categorical variables. There were no significant differences in the proportion of subjects in 
both age groups with BMI>97th percentile or hypertension (systolic and/or diastolic blood 
pressure ≥95th percentile for gender, age, and height). The only significant association found 
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was between age category and total cholesterol level (X2 6.276, p 0.012).  There was no 
significant association between age category and serum triglyceride, HDL cholesterol, LDL 
cholesterol, or fasting blood sugar levels. Additionally, there were no significant differences 
in the number of obese children with metabolic syndrome between the two age categories (X2 
0.012, p 0.912). There were also no significant differences in the gender distribution of obese 
children in both age categories (X2 0.281, p 0.596). 
 
Table 4.3: COMPARISON OF CLINICAL PARAMETERS BY AGE CATEGORY  
 Age <10 
years 
Age ≥10 
years 
X2 (df) p-value Chi-
square 
p-value 
Fisher exact 
Gender (n=84)             
Male                 
Female 
                                  
28 (68.3%)                              
13 (31.7%) 
                                
27 (68.3%)            
16 (37.2%) 0.28 (1) 
 
0.596 
 
0.651 
Hypertension 
(n=82)          
Yes                
No               
                           
23(56.1%)      
18(43.9%) 
                             
26 (60.5%)      
17 (39.5%) 
0.33 (1) 
 
0.796 
 
0.637 
BMI (n=84)             
<97th percentile 
>97th percentile 
                             
2 (5%)                       
38 (95%) 
                            
3 (6.9%)             
40 (93.1%) 0.004 (1) 
 
0.912 
 
1 
Metabolic synd     
Absent               
Present 
                        
30 (73.2%)   
11 (26.8%) 
                          
31 (72.1%)       
12 (27.9%) 
 
0.012 (1) 
 
0.0912 
 
1 
 
 
 
 
 
 
 
